公司概覽
業務類別 Drug Manufacturers - Specialty & Generic
業務概覽 United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United Statesand Rest of the World, of which United States generates majority of the revenue.
公司地址 1000 Spring Street, Silver Spring, MD, USA, 20910
電話號碼 +1 301 608-9292
傳真號碼 +1 301 608-9291
公司網頁 https://www.unither.com
員工數量 1400
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD Chairperson of the Board and Chief Executive Officer 美元 1.55M 29/04/2026
Mr. Paul A. Mahon,J.D. Executive Vice President, General Counsel and Corporate Secretary 美元 964.23K 29/04/2026
Mr. James C. Edgemond Chief Financial Officer, Principal Accounting Officer and Treasurer 美元 955.77K 29/04/2026
Mr. Michael Benkowitz President and Chief Operating Officer 美元 1.44M 29/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Christopher Patusky,J.D. Vice Chairman of the Board and Lead Independent Director 29/04/2026
Dr. Louis W. Sullivan, M.D. Independent Director 29/04/2026
Mr. Raymond C. Kurzweil Independent Director 29/04/2026
Governor Tommy G. Thompson, J.D. Independent Director 29/04/2026
Dr. Victor J. Dzau,M.D. Director 23/07/2026
Mr. Christopher Causey,M.B.A. Independent Director 29/04/2026
Dr. Martine A. Rothblatt, J.D.,M.B.A.,PhD Chairperson of the Board and Chief Executive Officer 29/04/2026
Mr. Richard Giltner Independent Director 29/04/2026
Dr. Judy D. Olian, PhD Independent Director 29/04/2026
Ms. Nilda Mesa, J.D. Independent Director 29/04/2026
Dr. Linda Maxwell, M.B.A.,M.D. Independent Director 29/04/2026
Ms. Jan Malcolm Independent Director 29/04/2026
Mr. Kevin J. Tracey, M.D. Director 22/01/2026
 
所屬ETF (更新日期: 19/09/2026 04:05)
代號 名稱 佔比% ▼ 持有日期
KNOAXS Knowledge Leaders ETF0.002%31/08/2026
VOTETCW Transform 500 ETF0.001%31/08/2026
VSMVVictoryShares US Mult-Fctr Mnmm Vltl ETF0.001%31/08/2026
MIDUDirexion Daily Mid Cap Bull 3X ETF0.001%31/08/2026
ILCViShares Morningstar Value ETF0.001%31/08/2026
FSGSFirst Trust SMID Growth Strength ETF0.001%31/08/2026
VSLUApplied Finance Valuation LgCp ETF0.001%31/08/2026
FDRSFounder-Led ETF0.001%31/08/2026
TAXCambria Tax Aware ETF0.001%31/08/2026
EQLALPS Equal Sector Weight ETF0.001%31/08/2026
ESUMEventide US Market ETF0.001%31/08/2026
GVUSGoldman Sachs MktBt Russell LgCpValEqETF0.001%31/08/2026
CVMCCalvert US Mid-Cp Cor Rspnb ETF0.001%31/08/2026
QLVNorthern Trust US Quality Lw Volatil ETF0.001%31/08/2026
VLUState Street® SPDR® S&P® 1500 ValTiltETF0.001%31/08/2026
JUSTGoldman Sachs JUST US Large Cap Eq ETF0.001%31/08/2026
REVSColumbia Research Enhanced Value ETF0.001%29/08/2026
KOKUXtrackers MSCI Kokusai Equity ETF0.001%31/08/2026
AQLTiShares MSCI Global Quality Factor ETF0.001%31/08/2026
SFYSoFi Select 500 ETF0.001%31/08/2026
  1    2    3    4    5    6    7    8    9   10    11    12    13  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.